About HyTest
HyTest is a company based in Turku (Finland) founded in 1994 was acquired by Mindray in May 2021. HyTest offers products and services including Monoclonal Antibodies, Antigens, Polyclonal Antibodies, and Sera and Plasma Products. HyTest operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Turku, Finland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hytest Ltd.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HyTest
HyTest offers a comprehensive portfolio of products and services, including Monoclonal Antibodies, Antigens, Polyclonal Antibodies, and Sera and Plasma Products.
Antibodies used for developing laboratory tests worldwide
Components for immunoassay and test development applications
Antibodies for various clinical assay developments
Products supporting blood-related diagnostic tests
Funding Insights of HyTest
Detailed funding history for HyTest
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in HyTest
HyTest has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Mindray and Summa Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summa Equity is focused on thematic and impact investments.
|
Locked | Locked | Locked | |
|
Provider of medical equipment & accessories for both human and veterinary
|
Locked | Locked | Locked |
Investor details for HyTest
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HyTest
Investment portfolio details for HyTest
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HyTest
Detailed financials for HyTest
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hytest Comparisons
Peer comparison for HyTest
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HyTest
HyTest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of HyTest
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hytest
Complete news archive for HyTest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HyTest
HyTest was founded in 1994.
HyTest is headquartered in Turku, Finland. It is registered at Turku, Varsinais-suomi, Finland.
Founded in 1994 and based in Turku, Finland, HyTest specializes in the development, production, and marketing of immunological reagents, including monoclonal and polyclonal antibodies, sera, plasma, and antigens. These products target areas such as cardiovascular disease, inflammation, infectious diseases, autoimmune diseases, veterinary applications, microbial, and plant toxins. An exclusive agreement has been established with Affinity Life Sciences for assays based on their patented SES-BNP technology to detect proBNP and BNP.
HyTest's top competitors include Sino Biological, GenScript and Y-Biologics.
HyTest offers Monoclonal Antibodies, Antigens, Polyclonal Antibodies, and Sera and Plasma Products.
HyTest has 2 investors. Key investors include Mindray, and Summa Equity.